Therma Bright (TSE:THRM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Therma Bright has signed a letter of intent with DME Authority to expand the U.S. distribution of its Venowave VW5 devices, targeting a $6 million inventory purchase within the first half of 2025. This partnership aims to enhance patient access to the mobile mechanical compression solution across multiple healthcare channels.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.